Protecting Children from Experimentation Act of 2025

Bill Number

H.R. 3688

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Crime and Law Enforcement

Status

Introduced

Latest Action

2025-06-03: Referred to the House Committee on the Judiciary.

Last Updated

2025-09-19T08:07:39Z

AI-Generated Summary

Purpose

The legislation, titled the "Protecting Children from Experimentation Act of 2025," aims to prohibit medical professionals from performing or assisting with gender transition procedures—such as hormone treatments or surgeries—on individuals under 18 years old. It seeks to protect minors from what the bill describes as experimental interventions by establishing federal criminal penalties, while allowing exceptions for certain medical conditions.

Key Provisions

• Criminal Prohibition: Adds a new section (2260B) to Chapter 110 of Title 18 of the U.S. Code, making it a federal crime for any physical or mental health care professional to knowingly perform or aid in a gender transition procedure on a minor. Penalties include fines, up to 5 years in prison, or both.
• Jurisdictional Triggers: The prohibition applies if the procedure involves interstate or foreign commerce, such as travel across state lines, use of interstate payment systems, communications via mail or internet, or tools that have crossed state lines. It also covers acts in U.S. territories or those affecting interstate commerce.
• Protections for Minors: Minors who receive the procedure cannot be arrested or prosecuted. They may file civil lawsuits against the health care provider for relief, such as damages.
• Definitions:
• Sex: Biologically determined as male (reproductive system that produces, transports, or utilizes sperm) or female (reproductive system that produces, transports, or utilizes eggs), accounting for natural anomalies or disruptions.
• Gender Transition: A process where an individual changes from identifying with their biological sex to a self-proclaimed identity that differs from it, potentially involving social, legal, or physical changes.
• Gender Transition Procedure: Includes a wide range of hormonal (e.g., puberty blockers, high-dose hormones) and surgical interventions (e.g., mastectomy, hysterectomy, phalloplasty, castration). Excludes treatments for:
• Disorders of sex development (e.g., ambiguous genitalia or chromosomal issues verified by medical testing).
• Infections, injuries, or life-threatening physical conditions unrelated to gender identity.
• Precocious puberty (early puberty normalization).
• Male circumcision.
• Scope: Applies only to minors (under 18) and requires knowing intent by the provider.

Significant Changes to Existing Law

• Introduces a new federal criminal offense in the U.S. Code, expanding Chapter 110 (which covers sexual exploitation and abuse) to include gender transition procedures on minors.
• Establishes federal jurisdiction over what is often regulated at the state level, using interstate commerce clauses to override purely intrastate activities.
• Creates a private right of action for civil suits by affected minors, which did not previously exist federally for this context.
• No amendments to existing protections for medical care; instead, it carves out specific prohibitions and exceptions without altering broader health laws.

Potential Impacts

• On Government Agencies: The Department of Justice would enforce the criminal provisions, potentially increasing federal investigations and prosecutions of health care providers. This could strain resources in the judiciary and health oversight bodies like the Department of Health and Human Services.
• On Citizens: Limits access to gender-affirming care for transgender minors nationwide, affecting families who might travel across states for treatment. Minors and parents could face restricted options, while enabling civil lawsuits might deter providers from offering care even in permissive states.
• On International Relations: Minimal direct impact, though it could influence U.S. stances in global health discussions on transgender rights or medical ethics, potentially drawing criticism from countries with more inclusive policies.

Main Stakeholders Affected

• Health Care Professionals: Doctors, therapists, and others who provide gender-related care face criminal and civil liability risks.
• Minors and Families: Transgender youth under 18 and their parents/guardians may lose access to certain treatments, with options for legal recourse if procedures occur.
• Medical and Advocacy Organizations: Groups like the American Medical Association or LGBTQ+ rights organizations could be involved in challenges or compliance efforts.
• State Governments: States with existing bans or protections on such care may see federal law preempt or conflict with local policies.

Notable Legal, Constitutional, or Political Implications

• Legal: Relies on the Commerce Clause (U.S. Constitution, Article I, Section 8) for federal authority, which could be challenged in court for overreaching into state-regulated medicine. The bill's definitions of "sex" and exclusions may invite disputes over medical necessity and First Amendment rights for providers' speech or beliefs.
• Constitutional: Potential conflicts with the Fourteenth Amendment's equal protection clause, as it disproportionately affects transgender individuals, and privacy rights under cases like Griswold v. Connecticut (1965) regarding bodily autonomy. Civil suit provisions could raise due process concerns if applied retroactively.
• Political: Likely to spark partisan debate, with supporters viewing it as child protection and opponents as discriminatory. It aligns with ongoing state-level restrictions but escalates to federal level, possibly influencing future elections or Supreme Court reviews on gender identity issues.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. LaMalfa, Doug [R-CA-1]

Cosponsors (18)

Rep. Grothman, Glenn [R-WI-6], Rep. Miller, Mary E. [R-IL-15], Rep. Gosar, Paul A. [R-AZ-9], Rep. Nehls, Troy E. [R-TX-22], Rep. Tenney, Claudia [R-NY-24], Rep. Boebert, Lauren [R-CO-4], Rep. Rouzer, David [R-NC-7], Rep. Arrington, Jodey C. [R-TX-19], Rep. Weber, Randy K. Sr. [R-TX-14], Rep. Palmer, Gary J. [R-AL-6], Rep. Bost, Mike [R-IL-12], Rep. Carter, John R. [R-TX-31], Rep. Harshbarger, Diana [R-TN-1], Rep. Babin, Brian [R-TX-36], Rep. Westerman, Bruce [R-AR-4], Rep. Mills, Cory [R-FL-7], Rep. Self, Keith [R-TX-3], Rep. Barr, Andy [R-KY-6]

Recent Actions

• 2025-06-03: Referred to the House Committee on the Judiciary.
• 2025-06-03: Introduced in House
• 2025-06-03: Introduced in House

Bill Versions

• Protecting Children from Experimentation Act of 2025 — issued 2025-06-03 — PDF (9 pages)